JUBLPHARMA.BO
Price:
$1076.4
Market Cap:
$170.18B
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Generics, Contract Research Development & Manufacturing Organisation (CRDMO), and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. The Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom immunotherapy products. The CDMO Steri...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-01-03
Stock Exchange
BSE
Ticker
JUBLPHARMA.BO
According to Jubilant Pharmova Limited’s latest financial reports and current stock price. The company's current PE Ratio is 35.84. This represents a change of -4.04% compared to the average of 37.35 of the last 4 quarters.
The mean historical PE Ratio of Jubilant Pharmova Limited over the last ten years is 17.95. The current 35.84 PE Ratio has changed 19.86% with respect to the historical average. Over the past ten years (40 quarters), JUBLPHARMA.BO's PE Ratio was at its highest in in the June 2023 quarter at 249.09. The PE Ratio was at its lowest in in the December 2022 quarter at -95.60.
Average
17.95
Median
17.77
Minimum
-72.75
Maximum
118.23
Discovering the peaks and valleys of Jubilant Pharmova Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 222.62%
Maximum Annual PE Ratio = 118.23
Minimum Annual Increase = -587.32%
Minimum Annual PE Ratio = -72.75
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 17.35 | -85.32% |
| 2024 | 118.23 | -262.51% |
| 2023 | -72.75 | -587.32% |
| 2022 | 14.93 | -20.99% |
| 2021 | 18.89 | 222.62% |
| 2020 | 5.86 | -67.81% |
| 2019 | 18.19 | -11.41% |
| 2018 | 20.54 | -5.22% |
| 2017 | 21.67 | 30.37% |
| 2016 | 16.62 | -139.46% |
The current PE Ratio of Jubilant Pharmova Limited (JUBLPHARMA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.94
5-year avg
19.33
10-year avg
17.95
Jubilant Pharmova Limited’s PE Ratio is greater than Alembic Pharmaceuticals Limited (27.88), greater than Alembic Pharmaceuticals Limited (27.88), less than Eris Lifesciences Limited (50.87), greater than Caplin Point Laboratories Limited (25.35), less than Eris Lifesciences Limited (50.87), greater than NATCO Pharma Limited (9.85), greater than NATCO Pharma Limited (9.85), greater than Granules India Limited (26.55), greater than Granules India Limited (26.55), less than Poly Medicure Limited (53.18),
| Company | PE Ratio | Market cap |
|---|---|---|
| 27.88 | $176.89B | |
| 27.88 | $176.87B | |
| 50.87 | $211.51B | |
| 25.35 | $149.24B | |
| 50.87 | $211.37B | |
| 9.85 | $167.22B | |
| 9.85 | $167.22B | |
| 26.55 | $136.10B | |
| 26.55 | $136.05B | |
| 53.18 | $192.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jubilant Pharmova Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jubilant Pharmova Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Jubilant Pharmova Limited's PE Ratio?
How is the PE Ratio calculated for Jubilant Pharmova Limited (JUBLPHARMA.BO)?
What is the highest PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO)?
What is the 3-year average PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO)?
What is the 5-year average PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO)?
How does the current PE Ratio for Jubilant Pharmova Limited (JUBLPHARMA.BO) compare to its historical average?